TGA / PMDA / NMPA · Asia-Pacific
haemophilus — TGA / PMDA / NMPA regulatory status
haemophilus regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 2 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free) | Phase 2 | BRIGHT MINDS BIOSCIENCES | NCT02919293 |
| VAN00013 | Phase 2 | Sanofi-Aventis U.S | 2023-510465-10-00 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12220453 | Compositions and treatments for Haemophilus influenzae | US |
| 11305002 | Compositions and treatments for Haemophilus influenzae | US |
| 9034642 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | US |
| 8911743 | Haemophilus parasuis polypeptides and methods of use | US |
| 8628917 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | US |
| 8283114 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | US |
| 7998490 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | US |
| 7816086 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | US |
| 7638282 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | US |
| 7514529 | Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines | US |
| 7241867 | Polypeptide encoded by a nucleotide sequence of a nontypeable strain of Haemophilus influenzae genome | US |
| 6607725 | Conjugate vaccine for nontypeable Haemophilus influenzae | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of haemophilus?
haemophilus currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get haemophilus regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to haemophilus?
This spoke lists 2 published programs associated with haemophilus in our pipeline index.